Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
Not yet recruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
September 15, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
Conditions
Long QT Syndrome Type 3Long QT Syndrome 2
Trial Locations (1)
27858
East Carolina University, Greenville
All Listed Sponsors
lead
Thryv Therapeutics, Inc.
INDUSTRY
NCT07075445 - Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3 | Biotech Hunter | Biotech Hunter